(Q40197908)

English

Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes

scientific article published on 29 June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1 reference

based on heuristic

inferred from title

author name string

Zi Yi Lim

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Laurence Pearce

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Aloysius Y Ho

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Linda Barber

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Wendy Ingram

5

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Monica Usai

6

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Khalid Tobal

7

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Stephen Devereux

8

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Antonio Pagliuca

9

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Ghulam J Mufti

10

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

language of work or name

0 references

publication date

29 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

138

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

517-526

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Bl

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06676.X

21 January 2018

Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06676.X

21 January 2018

T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06676.X

21 January 2018

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06676.X

21 January 2018

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06676.X

21 January 2018

Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06676.X

21 January 2018

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06676.X

21 January 2018

Roles of deletion and regulation in creating mixed chimerism and allograft tolerance using a nonlymphoablative irradiation-free protocol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06676.X

21 January 2018

Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06676.X

21 January 2018

Mixed hematopoietic chimerism at day 90 following allogenic myeloablative stem cell transplantation is a predictor of relapse and survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06676.X

21 January 2018

Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06676.X

21 January 2018

The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06676.X

21 January 2018

Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06676.X

21 January 2018

Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06676.X

21 January 2018

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06676.X

21 January 2018

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06676.X

21 January 2018

Mixed hematopoietic chimerism for the simultaneous induction of T and B cell tolerance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06676.X

21 January 2018

Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06676.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2007.06676.X

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40197908&oldid=1888569688"